MICHELLE ZINN: Open Payments
NPI 1922400480 · MIDDLETOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$649 in 40 payments from 7 companies in 2025. Trend: 2023 $509 · 2024 $698 · 2025 $649
Food & beverage: $649
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $285 |
| Boston Scientific Corporation | 10 | $138 |
| AstraZeneca Pharmaceuticals LP | 4 | $80 |
| Exact Sciences Corporation | 3 | $54 |
| Axsome Therapeutics, Inc. | 3 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Lilly USA, LLC | 1 | $19 |
Products named: VRAYLAR, QULIPTA, BREZTRI, Cologuard Collection Kit, Auvelity, UBRELVY, Apollo REVISE NXT System, EXALT Model D.
Industry payments across NY — which companies pay providers there.
